Evidence map›Paper›PMID 38994982›Full record

ReviewCells2024

Effects of Cannabis on Glutamatergic Neurotransmission: The Interplay between Cannabinoids and Glutamate.

Kawsar U Chowdhury, Madison Elizabeth Holden, Miles T Wiley, Vishnu Suppiramaniam, Miranda N Reed

Abstract readReview
In one paragraph

Review in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review
  3. Article
  4. Adolescent ΔPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kawsar U ChowdhuryDepartment of Drug Discovery and Development, Auburn University, Auburn, AL 36849, USA.
Madison Elizabeth HoldenCollege of Science and Mathematics, Auburn University, Auburn, AL 36849, USA.
Miles T WileyDepartment of Drug Discovery and Development, Auburn University, Auburn, AL 36849, USA.
Vishnu SuppiramaniamDepartment of Drug Discovery and Development, Auburn University, Auburn, AL 36849, USA.
Miranda N ReedDepartment of Drug Discovery and Development, Auburn University, Auburn, AL 36849, USA.ORCID 0000-0002-8465-5594

Funding

Elucidation of molecular mechanisms of prenatal cannabinoid exposure: Identification of targets and therapies.R01DA046723 · NIDA · KENNESAW STATE UNIVERSITY · PI REED, MIRANDA NICOLE, SUPPIRAMANIAM, VISHNU · 2020 to 2024
$1.6M
G-RISE at Auburn UniversityT32GM141739 · NIGMS · AUBURN UNIVERSITY AT AUBURN · PI CLAYTON, TAFFYE BENSON, RUSSELL, MELODY L · 2021 to 2024
$1.2M
NIGMS NIH HHS T32 GM141739NIH HHS R01 DA046723-01A1
6 · The paper itself

Abstract

There has been a significant increase in the consumption of cannabis for both recreational and medicinal purposes in recent years, and its use can have long-term consequences on cognitive functions, including memory. Here, we review the immediate and long-term effects of cannabis and its derivatives on glutamatergic neurotransmission, with a focus on both the presynaptic and postsynaptic alterations. Several factors can influence cannabinoid-mediated changes in glutamatergic neurotransmission, including dosage, sex, age, and frequency of use. Acute exposure to cannabis typically inhibits glutamate release, whereas chronic use tends to increase glutamate release. Conversely, the postsynaptic alterations are more complicated than the presynaptic effects, as cannabis can affect the glutamate receptor expression and the downstream signaling of glutamate. All these effects ultimately influence cognitive functions, particularly memory. This review will cover the current research on glutamate-cannabis interactions, as well as the future directions of research needed to understand cannabis-related health effects and neurological and psychological aspects of cannabis use.

Indexed as

CannabinoidsCannabisGlutamic AcidSynaptic TransmissionAnimalsHumansCannabinoidsGlutamic AcidcannabinoidglutamateLTPmemorysynapse

Identifiers

PMID38994982
PMCPMC11240741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.